Skip to content
Home/Companies/Biotech/MedDay Pharmaceuticals

MedDay Pharmaceuticals

Biotech·France·Exited 2021·Held 5yr
Entry
2016
Hold
5yr
Exit
2021

Who owns MedDay Pharmaceuticals?

MedDay Pharmaceuticals is a French Biotech company, formerly owned by Andera Partners, exited in 2021 (exit via Trade Sale). No current private equity owner is on file.

Hand-verified · updated 2026-04-21

Open JSON · CC-BY
Andera Partners
Investor
Andera Partners
BioDiscovery 4 · 2013 · VC

Key facts

HQFrance
SectorBiotech
Exit Type
Trade Sale
Exit Year
2021

More from BioDiscovery 4

Other portfolio companies in the same fund.

Inotrem
Active
BiotechFrance
Verona Pharma
Verona Pharma
Exited 2017
BiotechUK· 2016
Autonomic Technologies
Exited 2020
MedTechUS· 2015
to Unity HA
Gamamabs
Active
BiotechFrance· 2015
ReViral
Exited 2022
BiotechUK· 2015
to Pfizer
Sanifit
Exited 2021
BiotechSpain· 2015
to Vifor Pharma

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns MedDay Pharmaceuticals?

MedDay Pharmaceuticals was formerly owned by Andera Partners, exited in 2021. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue